Arcadia biosciences, inc. (RKDA)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-15,794

-24,769

-22,106

-15,707

-18,455

-18,105

-18,650

-19,624

-17,773

-18,217

-17,343

-17,956

-16,087

-18,532

-20,666

-18,339

0

0

0

Adjustments to reconcile net income (loss) to cash used in operating activities:
Initial loss on common stock warrant and common stock adjustment feature liabilities

-

-

-

-

-

4,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of common stock warrant liabilities

-7,413

9,243

3,215

-12,983

-2,966

-9,561

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Offering costs

-

-

-

-

-

2,555

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

0

0

0

-

292

303

318

304

311

300

289

294

296

316

336

358

0

0

0

Lease amortization

759

708

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss (gain) on disposal of equipment

-

-

-

-

-

3

1

1

1

1

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net amortization of investment premium

180

180

199

248

230

193

122

51

55

89

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Equity in loss of unconsolidated entity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-932

0

0

0

Stock-based compensation

2,637

2,287

2,422

1,705

1,674

1,550

1,295

1,370

1,401

1,474

1,575

1,426

1,209

1,059

848

861

1,226

1,392

1,586

1,501

1,162

976

0

0

0

Net amortization of investment premium and discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-140

0

0

0

-

-

-

-

-

-

-

-

Common stock warrants issued for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

93

0

0

0

Change in fair value of derivative liabilities related to convertible promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

835

1,917

1,989

611

0

0

0

Accretion of debt discount

-

-

-

-

-

-

-

-

-

98

148

199

199

198

396

592

744

837

715

503

459

468

0

0

0

Write down of inventory

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

230

437

-66

-55

27

-1,066

120

-252

-232

882

-24

255

-303

-357

-588

32

437

-336

627

-106

51

393

0

0

0

Unbilled revenue

-

-

-

-

-

-2

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amounts due from related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-100

0

0

0

Unbilled revenue

-

-

-

-

-

-

-

-

-

-

-83

49

6

102

-287

-120

-64

-298

-665

-423

-296

105

0

0

0

Inventories

5,719

1,535

1,552

627

-178

-160

-320

-269

-142

-183

-778

-741

-630

-582

-537

-493

-475

-412

295

-1,140

-787

-412

0

0

0

Prepaid expenses and other current assets

956

8

-147

211

88

151

-212

-682

-865

-324

-85

118

-52

185

532

659

1,080

415

0

0

0

-

-

-

-

Other noncurrent assets

0

-

-

-

-

-

-

-

-

-11

244

255

266

-5

-96

-41

111

-49

0

0

0

-

-

-

-

Accounts payable and accrued expenses

2,867

2,102

2,743

905

-40

176

441

560

-59

87

-752

-739

-609

-19

-1,314

-649

304

125

1,400

402

-514

-216

0

0

0

Amounts due to related parties

3

11

9

6

8

-1

-13

-15

-16

-1

0

0

0

-

-

5

-66

-37

-30

-35

-123

-140

0

0

0

Unearned revenue

-39

-54

23

-196

-256

-312

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease payments

-727

-715

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unearned revenue

-

-

-

-

-

-

-

-

-

-

49

-222

53

215

-256

-74

-485

-821

-1,366

-1,141

-973

-978

0

0

0

Net cash used in operating activities

-22,499

-17,198

-14,881

-15,142

-14,983

-13,631

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-16,730

-17,055

-16,724

-17,374

-17,366

-15,109

-13,821

-12,946

-15,259

-14,787

0

0

0

Cost method investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Proceeds from sale of property and equipment

-

-

-

-

-

10

10

9

9

4

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

2,167

1,477

1,039

497

305

250

91

89

55

79

86

91

151

231

293

326

281

151

0

0

0

-

-

-

-

Purchases of investments

22,960

28,358

0

0

0

-

-

-

-

19,405

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales and maturities of investments

27,450

21,450

33,250

33,400

29,450

24,150

17,830

30,773

55,863

66,658

73,846

63,895

40,545

36,315

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by investing activities

2,339

-8,369

6,740

13,304

-7,429

-5,975

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock and warrants from purchase agreement

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of offering costs relating to purchase agreement

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

8,205

0

0

0

-

-

-

-

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-5,569

-5,301

-36,094

-34,330

-36,025

-46,360

-11,478

-666

-898

-1,591

0

0

0

Payments of deferred offering costs

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

46

0

0

0

-

-

-

-

-

-

-

-

Principal payments on notes payable

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from ESPP purchases

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options and purchases through ESPP

-

-

-

-

-

969

969

974

974

24

38

185

319

442

620

605

497

360

0

0

0

-

-

-

-

Capital contributions received from non-controlling interest

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

22,695

21,986

22,013

6,817

12,432

22,479

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of redeemable convertible preferred stock and common stock warrants, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

32,845

0

0

0

Payments on notes payable and convertible promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

26,796

3,370

3,611

2,177

1,084

0

0

0

Capital lease payments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

318

396

325

-939

71,653

68,871

67,095

67,940

26,920

30,114

0

0

0

Net increase in cash and cash equivalents

-

-

-

-

-

-

-

-3,771

12,859

7,112

-7,543

-13,922

-21,981

-21,960

-52,493

-52,643

18,262

7,402

41,796

54,328

10,763

13,736

0

0

0

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

1,128

1,033

1,394

1,579

1,733

2,050

0

0

0

-

-

-

-

Cash paid for income taxes

-

2

12

12

12

34

0

0

0

-

-

-

-

29

2

2

2

149

0

0

0

-

-

-

-

Cash paid for interest

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NONCASH INVESTING AND FINANCING ACTIVITIES:
Fixed assets acquired with notes payable

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Offering costs in accounts payable and accrued expenses at end of period

-

20

0

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs in accounts payable and accrued expenses at end of period

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,574

0

0

0

-

-

-

-

Common stock warrants issued to placement agent and included in offering costs related to purchase agreement

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of fixed assets included in prepaid expenses and other current assets at end of period

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Right of use assets obtained in exchange for new operating lease liabilities

3,836

2,328

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs included in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

Purchases of fixed assets included in accounts payable and accrued expenses

-

1

0

0

0

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

Exchange of membership interest in unconsolidated entity for common stock

-

-

-

-

-

-

-

-

-

2

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividends to common stock warrant holder

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

197

0

0

0

-

-

-

-

June 2018 Offering [Member]
Payments of offering costs

-

24

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-